\begin{tabular}{lrrr}
\toprule
                                         Term name &  Adjusted p-value &   Z-score &  Combined score \\
\midrule
                        Hematopoietic cell lineage &      1.140881e-09 & 10.332538 &      269.936043 \\
                                           Malaria &      4.666333e-09 & 16.180393 &      388.703751 \\
               Complement and coagulation cascades &      3.236357e-06 &  8.300020 &      141.729803 \\
                       Hypertrophic cardiomyopathy &      4.447071e-06 &  7.759066 &      127.057202 \\
                         Th17 cell differentiation &      4.447071e-06 &  6.929002 &      112.576991 \\
                              Rheumatoid arthritis &      4.852632e-06 &  7.466952 &      119.304110 \\
                           Cell adhesion molecules &      5.804935e-06 &  5.594472 &       87.521495 \\
                          ECM-receptor interaction &      1.475529e-05 &  7.239752 &      105.540072 \\
                        Inflammatory bowel disease &      3.849478e-05 &  8.306579 &      112.148388 \\
AGE-RAGE signaling pathway in diabetic complica... &      4.767619e-05 &  6.248663 &       82.369145 \\
                         Graft-versus-host disease &      6.894878e-05 & 10.711093 &      136.219831 \\
                                            Asthma &      7.980453e-05 & 13.253198 &      165.458396 \\
                  Th1 and Th2 cell differentiation &      1.019752e-04 &  6.210572 &       75.515719 \\
                                 Viral myocarditis &      1.040863e-04 &  8.045080 &       97.060846 \\
                                     Leishmaniasis &      1.068279e-04 &  6.814639 &       81.241714 \\
           Human T-cell leukemia virus 1 infection &      1.068279e-04 &  3.879503 &       46.075101 \\
                   Staphylococcus aureus infection &      1.068279e-04 &  5.987844 &       70.922823 \\
      Intestinal immune network for IgA production &      1.201193e-04 &  9.101632 &      106.216430 \\
                               Allograft rejection &      2.119925e-04 & 10.256864 &      113.316917 \\
                          Type I diabetes mellitus &      4.680452e-04 &  8.830039 &       90.107039 \\
                                         Pertussis &      4.914000e-04 &  6.118845 &       61.843896 \\
                            Dilated cardiomyopathy &      5.435290e-04 &  5.303905 &       52.825698 \\
               Antigen processing and presentation &      5.526586e-04 &  5.940878 &       58.806760 \\
                        JAK-STAT signaling pathway &      6.213059e-04 &  3.994903 &       38.906452 \\
                                       Influenza A &      1.099569e-03 &  3.741723 &       34.152017 \\
                                Insulin resistance &      1.233122e-03 &  4.651580 &       41.671406 \\
                                         Phagosome &      1.233122e-03 &  3.917244 &       35.003546 \\
                            PPAR signaling pathway &      1.880340e-03 &  5.508794 &       46.700735 \\
            Fluid shear stress and atherosclerosis &      2.125901e-03 &  3.920646 &       32.618417 \\
                        PI3K-Akt signaling pathway &      2.673997e-03 &  2.608955 &       21.018717 \\
                                        Amoebiasis &      3.250730e-03 &  4.402321 &       34.462595 \\
                        Osteoclast differentiation &      3.806723e-03 &  3.892392 &       29.732580 \\
                                    Focal adhesion &      3.812298e-03 &  3.159813 &       24.020252 \\
                                          Lysosome &      3.812298e-03 &  3.859207 &       29.239482 \\
                               Coronavirus disease &      4.372700e-03 &  2.936973 &       21.711965 \\
                                      Tuberculosis &      4.372700e-03 &  3.259664 &       24.063638 \\
                                Pathways in cancer &      4.608300e-03 &  2.184163 &       15.914451 \\
                Vascular smooth muscle contraction &      4.608300e-03 &  3.701377 &       26.930104 \\
                                     Toxoplasmosis &      5.120986e-03 &  3.972870 &       28.383121 \\
            Cytokine-cytokine receptor interaction &      5.225583e-03 &  2.626823 &       18.647026 \\
                        Autoimmune thyroid disease &      6.250531e-03 &  5.780520 &       39.856145 \\
           Transcriptional misregulation in cancer &      6.594012e-03 &  3.040471 &       20.727840 \\
                           African trypanosomiasis &      7.014765e-03 &  7.064164 &       47.555438 \\
   Arrhythmogenic right ventricular cardiomyopathy &      8.405530e-03 &  4.533256 &       29.593390 \\
                         Relaxin signaling pathway &      1.197605e-02 &  3.407068 &       20.958827 \\
                      Systemic lupus erythematosus &      1.594520e-02 &  3.243825 &       18.954792 \\
                         Type II diabetes mellitus &      1.719031e-02 &  5.510953 &       31.669525 \\
                   Adipocytokine signaling pathway &      2.081925e-02 &  4.308916 &       23.845826 \\
                           IL-17 signaling pathway &      2.326394e-02 &  3.644266 &       19.660231 \\
                            Cholesterol metabolism &      2.326394e-02 &  5.020062 &       27.019063 \\
                            MAPK signaling pathway &      2.726581e-02 &  2.279314 &       11.860835 \\
                                     Axon guidance &      3.338445e-02 &  2.640243 &       13.153191 \\
                                    Chagas disease &      3.373253e-02 &  3.336010 &       16.521222 \\
                       Chemokine signaling pathway &      4.599311e-02 &  2.493888 &       11.530912 \\
                                Yersinia infection &      4.856731e-02 &  2.809346 &       12.784942 \\
                   Human cytomegalovirus infection &      4.913023e-02 &  2.334683 &       10.555843 \\
\bottomrule
\end{tabular}
